The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Items 701–800 of 918
Nicolaides, N. C., Makridakis, M., Stroggilos, R., Lygirou, V., Koniari, E., Papageorgiou, I., Sertedaki, A., Zoidakis, J., & Charmandari, E. (2022) · Biomedicines · doi:10.3390/biomedicines10010184 · Cited by 4
“Moreover, the ligand-bound GR may influence gene expression in a positive or negative fashion through protein–protein interactions with other transcription factors, including the nuclear factor-κB (NF-κB) [4], signal transducers and activators of transcription (STATs) [5], and the activator protein-1 (AP-1) [4,6].”
BackgroundZhu, J., Wu, R., Yang, T., Yuan, Y., Liu, G., Chen, S., Chen, Z., Liu, S., Wang, S., Li, D., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001101 · Cited by 4
“[11] The monoclonal antibody tocilizumab targeting the IL-6 receptor and anakinra antagonizing the IL-1 receptor have been reported to be effective in treating severe cases of rheumatoid arthritis and systemic lupus erythematosus, respectively.”
Bjelaković, G., Stojanović, I. R., Jevtović−Stoimenov, T., Pavlovic, D. D., Kocic, G. M., Kamenov, Β., Šaranac, L., Nikolić, J., Bjelakovic, B. B., Sokolovic, D. T., et al. (2009) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2009.20.2.99 · Cited by 7
Liddicoat, D. R., Purton, J. F., Cole, T. J., & Godfrey, D. I. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.76 · Cited by 4
Possible Genetic Dysregulation in Pediatric CFS
Jason, L. A., Sorenson, M., Porter, N. S., Brown, M. M., Lerch, A., der Eb, C. V., & Mikovits, J. A. (2010) · Psychology · doi:10.4236/psych.2010.14033 · Cited by 4
Ruiz, M., Hedman‐Lagerlöf, E., Gåfvels, M. E., Eggertsen, G., Werner, S., Wahrenberg, H., & Wikström, A. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.764573 · Cited by 4
Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
Stefanaki, C., Chrousos, G. P., & Katsambas, A. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.06.011 · Cited by 4
Oakley, R. H., & Cidlowski, J. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_4 · Cited by 4
GOODMAN, H. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373975-9.00004-5 · Cited by 5
Expression and regulation of M-type K+ channel in PC12 cells and rat adrenal medullary cells
Harada, K., Matsuoka, H., & Inoue, M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2809-y · Cited by 4
Song, J. (2026) · iScience · doi:10.1016/j.isci.2026.115447 · Cited by 3
“Glucocorticoid-driven oxidative stress, microglial activation, and mitochondrial dysfunction Elevated norepinephrine 163 and cortisol levels further stimulate pro-inflammatory cytokine production 164 and overactivate the SNS, leading to severe inflammation 165 (Table 2).”
PKC-PKD-NFκB signalling induces cardiomyocyte t-tubule loss via a conserved macropinocytic mechanism
Martinez-Vilchez, A., Pfeuffer, A.-K. M., Wessolowski, J. S., Fiegle, D. J., Andrae, P., Potue, P., Küpfer, L. K., Shankar, T. S., Selzman, C. H., Drakos, S. G., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag121 · Cited by 3
The increasing complexity of glucocorticoid receptor signaling and regulation
Desmet, S. J., Beck, I. M. E., Bougarne, N., Clarisse, D., Deckers, J., Ratman, D., Tavernier, J. H., & Bosscher, K. D. (2014) · Ghent University Academic Bibliography (Ghent University) · Cited by 3
Zhu, X., Liu, Y., Diao, F., Fan, J., Lu, J., & Xu, R. (2007) · Endocrine · doi:10.1007/s12020-007-0019-6 · Cited by 3
Epigenetic Aberrations in Human Allergic Diseases
Amarasekera, M., Martino, D., Tulić, M. K., Saffery, R., & Prescott, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00018-4 · Cited by 3
Lakota, K., Hrušovar, D., Ogrič, M., Mrak‐Poljšak, K., Čučnik, S., Tomšič, M., Božič, B., Žigon, P., & Sodin-Semrl, S. (2018) · Mediators of Inflammation · doi:10.1155/2018/8237209 · Cited by 3
“Dexamethasone is a synthetic GC that binds to cytosolic glucocorticoid receptors, translocates to the nucleus, and physically interacts with NF-κB and AP-1 thereby affecting expression of IL-1, IL-6, TNFα, and VCAM, among others, and attenuating the inflammatory response [19, 20].”
BackgroundMeduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6206 · Cited by 3
“In parallel, receptor function may be compromised by oxidative stress, mitochondrial dysfunction, micronutrient depletion, and dysbiosis, all of which disrupt GR α expression, nuclear translocation, and downstream signaling.”
Molecular Mechanisms Conferring Resistance/Sensitivity to Glucocorticoid-Induced Apoptosis
Berrou, I., Krstic–Demonacos, M., & Demonacos, C. (2012) · InTech eBooks · doi:10.5772/51467 · Cited by 3
Disorder of Systemic Inflammation in Sepsis and Trauma: A Systems Perspective
Zettel, K. R., & Billiar, T. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8008-2_6 · Cited by 4
Higashigawa, M., Nakamura, T., Hattori, T., Yoshino, A., Ito, M., & Ichimi, R. (2019) · Minerva Pediatrics · doi:10.23736/s2724-5276.19.05567-1 · Cited by 3
Antioxidants and anti‐Inflammatories
Fuller, B. B. (2010) · Wiley eBooks · doi:10.1002/9781444317657.ch35 · Cited by 3
Endocrinology of Bone and Growth Disorders
Farquharson, C., Stephen, L. A., & Wong, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00086-4 · Cited by 3
A short review on the role of thyroxine in fast wound healing and tissue regeneration
Amin, M. F., Zubair, M. S., & Ammar, M. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102115 · Cited by 3
Sgambellone, S., Febo, M., Durante, M., Marri, S., Villano, S., Bereshchenko, O., Migliorati, G., Masini, E., Riccardi, C., Bruscoli, S., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01802-3 · Cited by 3
“Glucocorticoids (GCs), drugs widely used for the treat-ment of inflammatory and autoimmune diseases, perform their action by binding to glucocorticoid receptors (GRs) in the cytoplasm [12].”
BackgroundEnhancing Nuclear Translocation: Perspectives in Inhaled Corticosteroid Therapy
Hakim, A., & Usmani, O. S. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.10 · Cited by 3
From the Obscure and Mysterious Acute Phase Response to Toll-Like Receptors and the Cytokine Network
Koj, A. (2008) · Current Immunology Reviews · doi:10.2174/157339508786447922 · Cited by 3
BenMohamed, F., Ruchon, Y., Capuano, V., & Renaud, J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0239-6 · Cited by 3
Behavioral Medical Epigenetics
Cox, O., & Lee, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803239-8.00008-9 · Cited by 4
Glucocorticoid Receptors, Their Mechanisms of Action, and Glucocorticoid Resistance
Cidlowski, J. A., Malchoff, C. D., & Malchoff, D. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00098-6 · Cited by 5
Stress-Induced Immune Dysfunction: Implications for Intrapersonal and Interpersonal Processes
Sepehrinezhad, A., Momeni, J., Gorji, A., & Negah, S. S. (2020) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.2.93 · Cited by 3
Manjur, A. B. M. K., Lempiäinen, J. K., Malinen, M., Varjosalo, M. T., Palvimo, J. J., & Niskanen, E. A. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105873 · Cited by 3
Anthrax Lethal Factor Represses Glucocorticoid and Progesterone Receptor Activity
Webster, J. I., Moayeri, M., & Sternberg, E. M. (2006) · Springer eBooks · doi:10.1007/978-0-387-48334-4_4 · Cited by 3
Yemelyanov, A. Y., Bhalla, P., Ugolkov, A. V., Yang, X. J., & Budunova, I. V. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3929 · Cited by 3
Modulation of glucocorticoid receptor function under iron overload
Zhu, W., Vanderhaeghen, T., Timmermans, S., Vandewalle, J., Eggermont, M., Verhoog, N. J. D., & Libert, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1605420 · Cited by 3
Sleep deprivation silently undermines immunity
Zhou, Q., Feng, C., Li, S., Zhangyan, M., & Sun, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004071 · Cited by 2
Spinelli, G., Biddeci, G., Iannolo, G., Colomba, P., Duro, G., Marsana, E. M., Aronica, T. S., & Blasi, F. D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1748334 · Cited by 2
Glucocorticoid receptor biology through the omics lens: context matters
Singh, P., & Greulich, F. (2026) · Biological Chemistry · doi:10.1515/hsz-2026-0147 · Cited by 2
“At certain locations, AP-1 occupancy has been found to be associated with reduced glucocorticoid-mediated repression or with competition for enhancer activity (De Bosscher et al. 2003; Jonat et al. 1990).”
Xue, H., Endo, T., Kadoya, K., Iwasaki, N., & Terkawi, M. A. (2026) · Bone Research · doi:10.1038/s41413-026-00576-8 · Cited by 2
Immunomodulatory and Anti-Inflammatory Properties of Glucocorticoids
Ayroldi, E., Migliorati, G., & Riccardi, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00052-9 · Cited by 2
Zhang, Y., Xia, M., Song, W., Li, D., Wei, X., & Wang, D. (2025) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545825500087 · Cited by 2
Jaskólska, M. M., Kościńska-Shukla, I., Jaskólski, D., Viti, A., Ziętkiewicz, M., & Chmielewski, M. S. (2025) · Stress · doi:10.1080/10253890.2024.2447868 · Cited by 2
“…short-standing stimulation, Gcs induce apoptosis in monocytes, macrophages and t-cells (amsterdam et al., 2002) and suppress the NF-kappaB pathway (de Bosscher et al., 2003). those phenomena result in a potent anti-inflammatory activity of Gcs. however, upon chronic exposure a process of…”
Antunica-Noguerol, M., Aprile-Garcia, F., Budziñski, M. L., Proto-Cassina, L., Liberman, A. C., & ARZT, E. S. (2014) · Advances in Neuroimmune Biology · doi:10.3233/nib-140083 · Cited by 2
“By this mechanism of transrepression, GR interferes with other TFs activities such as activating protein-1 (AP-1), NF-kB and Tbox expressed in T cells (T-bet) [35, 36].”
BackgroundMacromolecular synthesis inhibitors perturb glucocorticoid receptor trafficking
Dezitter, X., Masselot, B., Tardivel, M., Méreau-Richard, C., Formstecher, P., & Idziorek, T. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.04.008 · Cited by 2
Regulação da produção hormonal da glândula pineal de ratos por moduladores do processo inflamatório.
Paulo, S. (2009) · Cited by 2
Samadi, A. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-2983-7.00033-4 · Cited by 2
Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer
Martínez-Iglesias, O. A., Ruiz-Llorente, L., Contreras‐Jurado, C., & Aranda, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00001-9 · Cited by 2
Psychosocial stress, mental health and salivary cortisol in children and adolescents
Gustafsson, P. E. (2008) · DiVA (Linkoping University) · Cited by 7
11β-hydroxysteroid dehydrogenase type 1 : a new therapeutic target post-myocardial infarction?
McSweeney, S. J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
Stubsrud, E. (2005) · SUNScholar (Stellenbosch University) · Cited by 2
Pauli, J. R. (2005) · Americanae (AECID Library) · Cited by 4
Northcott, M., & Morand, E. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00006-3 · Cited by 1
Targeting cancer-inducing inflammation: Current advancements and future prospects
Chan, Y., Liew, H. S., Pua, L. J. W., Soon, L., Ng, S. W., Tan, J. Z. X., Chellappan, D. K., & Dua, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00001-2 · Cited by 1
Kondracki, M., Żmuda, A., Gryzińska, M., Mazurkiewicz, I., Seremak, B., Furmaga, J., & Jakubczak, A. (2025) · Animals · doi:10.3390/ani15162360 · Cited by 1
Souali‐Crespo, S., Rizk, J. G., Calvano, E., Sahu, R., Colovic, E., Chabba, I., Gilbart, V., Grandgirard, E., Morlet, B., Cai, Q., et al. (2026) · Advanced Science · doi:10.1002/advs.77653 · Cited by 1
Bao, X., Zhou, Y., Yang, Z., Zhong, Y., Hu, X., Li, Z., Li, J., Li, X., Hou, T., Weng, Q., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02983 · Cited by 2
Alpha-1 antitrypsin–glucocorticoid receptor axis: a new pathway in immune modulation
Möhlis, K., Held, J., Korenbaum, E., Wrenger, S., Janciauskiene, S. M., & Heiker, J. T. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01470-z · Cited by 1
Benavides, S., Kosyk, O., Wang, H., Bastian, A. G., Georgiou, C. E., Miller, B. C., Stanley, N., & Zannas, A. S. (2026) · Cell Genomics · doi:10.1016/j.xgen.2026.101330 · Cited by 1
Partsch, V., Crudo, F., Schröder, C., Favero, G. D., & Marko, D. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112357 · Cited by 2
Molecular Genomics of Mineralocorticoid Action
Fuller, P. J., & Young, M. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00043-7 · Cited by 1
The Glucocorticoid Receptor in Retroviral Infection
Fouty, B., & Solodushko, V. (2011) · InTech eBooks · doi:10.5772/21722 · Cited by 1
“…factors that regulate expression of pro-inflammatory genes and other genes involved in immune responses (Hapgood & Tomasicchio, 2010; De Bosscher et al., 2003; Smoak & Cidlowski, 2004) Vpr enhances the immunosuppressive effect of endogenous and therapeutic glucocorticoids (Mirani et…”
BackgroundThe Use of Glucocorticoids in the Treatment of Acute Asthma Exacerbations
Abdullah, A. (2012) · InTech eBooks · doi:10.5772/53221 · Cited by 1
“This process is called transrepression (De Bosscher et al, 2003) (figure 2).”
BackgroundNeural Functions of Hematopoietic‐derived Cells
Derecki, N. C., & Kipnis, J. (2013) · Wiley eBooks · doi:10.1002/9781118314814.ch6 · Cited by 1
Transcriptional Networks in Mammalian Gene Regulation
Shannon, M. F. (2006) · CRC Press eBooks · doi:10.1201/9781498713733-12 · Cited by 1
The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication
Benton, T. D., Lynch, K. G., Dubé, B., Gettes, D. R., Tustin, N. B., Metzger, D. S., Blume, J., Douglas, S. D., & Evans, D. L. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12060147 · Cited by 2
Zhu, W. (2015) · UKnowledge (University of Kentucky) · Cited by 1
1. Physiopathology of Adrenal Crisis
Suwa, T., & Mune, T. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.756 · Cited by 1
Zalachoras, I., & Meijer, O. C. (2016) · Epigenetics and human health · doi:10.1007/978-3-319-24493-8_3 · Cited by 1
Gehring, U. (2004) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-004-1035-4 · Cited by 4
Anandani, D. N., Shah, S., Belim, R. H., & Prajapati, A. (2019) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2019/562 · Cited by 1
“12, 2019 Page 2586 [15] De Bosscher K, Berghe VW, Haegeman G.”
Sun, Z., Zhang, X., Li, X., Huang, Y., Sui, S., Liu, W., Ni, G., Xu, X., Yang, J., Xue, L., et al. (2021) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20181228061204 · Cited by 1
“It has also been showed that GR interfered with the transcriptional activity of NF-κB and Activator protein 1 (AP-1), thus inhibiting the expression of inflammatory molecules such as IL-2, IL-6, IL-8, TNF-α and iNOS (De Bosscher et al., 2003).”
BackgroundAndriani, D. R., Pargaputri, A. F., Parisihni, K., & Revianti, S. (2021) · Archives of Orofacial Sciences · doi:10.21315/aos2021.16.s1.4 · Cited by 1
Oral and Parenteral Corticosteroid Therapy in Ulcerative Colitis
Afzali, A., Wheat, C. L., & Lee, S. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1677-1_9 · Cited by 1
Marine Compounds and Cancer 2017
Honecker, F. U., & Dyshlovoy, S. A. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-766-7 · Cited by 1
17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
Hu, T., Tang, C., Stern, S., Yang, L., & Du, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.831315 · Cited by 1
Disorder of Systemic Inflammation in Sepsis and Trauma: A Systems Perspective
Bonaroti, J. W., Zettel, K. R., Billiar, T. R., & Neal, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-56510-7_6 · Cited by 1
Exploring Asthma as a Protective Factor in COVID-19 Outcomes
Quinn, A. E., Zhao, L., Bell, S. D., Huq, M. H., & Fang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041678 · Cited by 1
Anti‐Inflammatory Glucocorticoids
Avery, M. A., & Chittiboyina, A. G. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc192 · Cited by 2
Knubel, K. H. (2010) · University Libraries (University of Maryland) · Cited by 2
C/EBP transcription factors in lung cellular differentiation and development
Berg, T. (2005) · Figshare · Cited by 1
Africander, D. (2010) · SUNScholar (Stellenbosch University) · Cited by 7
Young, S. A. (2016) · UA Campus Repository (The University of Arizona) · Cited by 1
O’Loughlin, A. (2011) · Maynooth University ePrints and eTheses Archive (Maynooth University) · Cited by 3
Transactivation versus transrepression in FXR: lessons learned from other Nuclear Receptors
Hollman, D. A. A. (2011) · Utrecht University Repository (Utrecht University)
Molecular mechanisms of apoptosis induced by dexamethasone in chronic lymphocytic leukemia
Baptista, G. M. L., & João, M. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Studies on the role of formyl peptide receptors in pituitary and adrenal function
Naughton, V. (2012) · Spiral (Imperial College London) · doi:10.25560/24934
Pulmonary Infections in Patients on Chronic Glucocorticoid Treatment
Rañó, A., & Agustí, C. (2009) · Wiley eBooks · doi:10.1002/9780470714171.ch10
Transcriptional regulation by the orphan nuclear receptor ERRgamma
Hirvonen, J. (2008) · Helda - University of Helsinki Institutional Repository
Hirschfelder, K. (2010) · Publications of the UdS (Saarland University) · doi:10.22028/d291-22666
“Our finding of NF-қB involvement are in accordance with the literature and also with the TLR2 downregulation observed after dexamethasone treatment, which is a well described inhibitor for NF-қB (Chinenov & Rogatsky, 2007; De Bosscher et al., 2003; De Bosscher et al., 1997).”
BackgroundResultAntioxidants and Anti‐inflammatories
Fuller, B. B. (2015) · Wiley eBooks · doi:10.1002/9781118655566.ch33 · Cited by 1
van Zuiden, M. (2012) · Utrecht University Repository (Utrecht University)
Factors Determining Glucocorticoid Sensitivity in Man
Smit, P. (2006) · EUR Research Repository (Erasmus University Rotterdam)
Downstream effects of master regulators in two brain diseases.
Braun, S. B. (2012) · Lund University Publications (Lund University)
TU3A is a novel stress-regulated protein involved in cognition and emotional behavior
Liebl, C. (2010) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.13730
Erekul, K. B. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7217
Studies of glucocorticoid receptor interacting proteins
Widén, C. (2005) · Figshare
Endothelial cells are a potential site of interaction between estrogens and glucocorticoids
Campos‐Rodríguez, R., Rivera‐Aguilar, V., Luna, R. A. J., Rojas-Hernández, S., Godínez‐Victoria, M., Abarca‐Rojano, E., Mera-Jiménez, E., Larsen, B. A., & Reséndiz‐Albor, A. A. (2009) · Bioscience hypotheses · doi:10.1016/j.bihy.2009.05.001
An efficient and economic high-throughput cell screening model targeting the glucocorticoid receptor
Zhang, Y., Guo, F., & Jiang, C. (2008) · Journal of drug targeting · doi:10.1080/10611860701725266
“…mechanisms of the GR action include physical interaction and inhibition of proinflammatory transcription factors, such as nuclear factor-kB (NF- kB) or activator protein-1 (AP-1), and post-transcrip- tional effects (Barnes 1998; De Bosscher et al. 2003; Smoak and Cidlowski 2004; Stellato 2004).”
BackgroundModulation of the HPA axis alters the sensitivity of the cochlea to acoustic trauma
Tahera, Y. (2006) · Figshare
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.